Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1541256
PUBLISHER: IMARC | PRODUCT CODE: 1541256
Asthma Therapeutics Market Report by Drug Class, Product Type, Treatment Type, Route of Administration, and Region 2024-2032
PUBLISHED:
PAGES: 141 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global asthma therapeutics market size reached US$ 18 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 22.0 Billion by 2032, exhibiting a growth rate (CAGR) of 1.9% during 2024-2032.
Asthma therapeutics refer to various pharmaceutical drugs that are used for the treatment of asthma. Asthma is usually triggered by indoor and outdoor causative agents, including pollution, allergens and dust. These therapeutics are usually bronchodilators and anti-inflammatory drugs, which include corticosteroids, long-acting beta-agonists (LABA), methylxanthine, immunomodulators and leukotriene modifiers. A number of combination therapy drugs are also used that can be inhaled, injected, or orally administered. These drugs expand the passageway into the lungs and enable the movement of air to improve breathing. They also aid in clearing mucus from the lungs that gets coughed out with ease.
Asthma Therapeutics Market Trends:
The increasing prevalence of asthma and other respiratory disorders, along with improvements in the diagnostic technologies, is one of the key factors driving the growth of the market. Furthermore, rising awareness among the masses regarding the availability of effective asthma therapeutics is also providing driving the market growth. For instance, asthmatic patients are primarily treated with inhaled corticosteroids and patients with advanced conditions or persistent asthma are treated with target-specific drugs. There is also an extensive demand for monoclonal antibodies (mAbs) that block immunoglobulin E and specific cytokines. The development of combination therapies for the treatment of respiratory diseases is acting as another growth-inducing factor. Increasing healthcare expenditures, extensive research, and development (R&D) activities in the field of medical sciences and improvements in the healthcare infrastructure are some of the other factors that are expected to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global asthma therapeutics market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on drug class, product type, treatment type and route of administration.
Breakup by Drug Class:
Anti-Inflammatory Drugs
Bronchodilators
Combination Therapies
Breakup by Product Type:
Inhalers
Dry Powder Inhalers
Metered Dose Inhalers
Soft Mist Inhalers
Nebulizers
Pneumatic Nebulizers
Ultrasonic Nebulizers
Mesh Nebulizers
Breakup by Treatment Type:
Quick-Relief Medications
Long-Term Asthma Control Medications
Breakup by Route of Administration:
Inhalation
Oral
Parenteral
Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being AstraZeneca PLC, Abbott Laboratories, Amgen Inc., Biogen Inc., Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Merck Sharp & Dohme Corp., Novartis International AG, Sunovion Pharmaceuticals Inc. and Teva Pharmaceutical Industries Ltd.
Key Questions Answered in This Report
- 1. What was the size of the global asthma therapeutics market in 2023?
- 2. What is the expected growth rate of the global asthma therapeutics market during 2024-2032?
- 3. What are the key factors driving the global asthma therapeutics market?
- 4. What has been the impact of COVID-19 on the global asthma therapeutics market?
- 5. What is the breakup of the global asthma therapeutics market based on the drug class?
- 6. What is the breakup of the global asthma therapeutics market based on the product type?
- 7. What is the breakup of the global asthma therapeutics market based on the treatment type?
- 8. What is the breakup of the global asthma therapeutics market based on the route of administration?
- 9. What are the key regions in the global asthma therapeutics market?
- 10. Who are the key players/companies in the global asthma therapeutics market?
Product Code: SR112024A2338
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Asthma Therapeutics Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Drug Class
- 6.1 Anti-Inflammatory Drugs
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Bronchodilators
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Combination Therapies
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by Product Type
- 7.1 Inhalers
- 7.1.1 Market Trends
- 7.1.2 Major Types
- 7.1.2.1 Dry Powder Inhalers
- 7.1.2.2 Metered Dose Inhalers
- 7.1.2.3 Soft Mist Inhalers
- 7.1.3 Market Forecast
- 7.2 Nebulizers
- 7.2.1 Market Trends
- 7.2.2 Major Types
- 7.2.2.1 Pneumatic Nebulizers
- 7.2.2.2 Ultrasonic Nebulizers
- 7.2.2.3 Mesh Nebulizers
- 7.2.3 Market Forecast
8 Market Breakup by Treatment Type
- 8.1 Quick-Relief Medications
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Long-Term Asthma Control Medications
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
9 Market Breakup by Route of Administration
- 9.1 Inhalation
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Oral
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Parenteral
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.1.1 United States
- 10.2 Asia Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.2.1 China
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.3.1 Germany
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.4.1 Brazil
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 AstraZeneca PLC
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.1.3 Financials
- 15.3.1.4 SWOT Analysis
- 15.3.2 Abbott Laboratories
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.2.3 Financials
- 15.3.2.4 SWOT Analysis
- 15.3.3 Amgen Inc.
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 Financials
- 15.3.3.4 SWOT Analysis
- 15.3.4 Biogen Inc.
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.4.3 Financials
- 15.3.4.4 SWOT Analysis
- 15.3.5 Boehringer Ingelheim International GmbH
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.6 F. Hoffmann-La Roche Ltd.
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.6.3 SWOT Analysis
- 15.3.7 GlaxoSmithKline Plc
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.7.3 Financials
- 15.3.7.4 SWOT Analysis
- 15.3.8 Merck Sharp & Dohme Corp.
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.8.3 Financials
- 15.3.8.4 SWOT Analysis
- 15.3.9 Novartis International AG
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.9.3 Financials
- 15.3.9.4 SWOT Analysis
- 15.3.10 Sunovion Pharmaceuticals Inc.
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.10.3 SWOT Analysis
- 15.3.11 Teva Pharmaceutical Industries Ltd.
- 15.3.11.1 Company Overview
- 15.3.11.2 Product Portfolio
- 15.3.11.3 Financials
- 15.3.11.4 SWOT Analysis
- 15.3.1 AstraZeneca PLC
Product Code: SR112024A2338
List of Figures
- Figure 1: Global: Asthma Therapeutics Market: Major Drivers and Challenges
- Figure 2: Global: Asthma Therapeutics Market: Sales Value (in Billion US$), 2018-2023
- Figure 3: Global: Asthma Therapeutics Market: Breakup by Drug Class (in %), 2023
- Figure 4: Global: Asthma Therapeutics Market: Breakup by Product Type (in %), 2023
- Figure 5: Global: Asthma Therapeutics Market: Breakup by Treatment Type (in %), 2023
- Figure 6: Global: Asthma Therapeutics Market: Breakup by Route of Administration (in %), 2023
- Figure 7: Global: Asthma Therapeutics Market: Breakup by Region (in %), 2023
- Figure 8: Global: Asthma Therapeutics Market Forecast: Sales Value (in Billion US$), 2024-2032
- Figure 9: Global: Asthma Therapeutics (Anti-Inflammatory Drugs) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 10: Global: Asthma Therapeutics (Anti-Inflammatory Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 11: Global: Asthma Therapeutics (Bronchodilators) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 12: Global: Asthma Therapeutics (Bronchodilators) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 13: Global: Asthma Therapeutics (Combination Therapies) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 14: Global: Asthma Therapeutics (Combination Therapies) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 15: Global: Asthma Therapeutics (Inhalers) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 16: Global: Asthma Therapeutics (Inhalers) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 17: Global: Asthma Therapeutics (Nebulizers) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 18: Global: Asthma Therapeutics (Nebulizers) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 19: Global: Asthma Therapeutics (Quick-Relief Medications) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 20: Global: Asthma Therapeutics (Quick-Relief Medications) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 21: Global: Asthma Therapeutics (Long-Term Asthma Control Medications) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 22: Global: Asthma Therapeutics (Long-Term Asthma Control Medications) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 23: Global: Asthma Therapeutics (Inhalation) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 24: Global: Asthma Therapeutics (Inhalation) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 25: Global: Asthma Therapeutics (Oral) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 26: Global: Asthma Therapeutics (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 27: Global: Asthma Therapeutics (Parenteral) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 28: Global: Asthma Therapeutics (Parenteral) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 29: North America: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 30: North America: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 31: United States: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 32: United States: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 33: Canada: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 34: Canada: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 35: Asia Pacific: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 36: Asia Pacific: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 37: China: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 38: China: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 39: Japan: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 40: Japan: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 41: India: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 42: India: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 43: South Korea: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 44: South Korea: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 45: Australia: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 46: Australia: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 47: Indonesia: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 48: Indonesia: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 49: Others: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 50: Others: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 51: Europe: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 52: Europe: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 53: Germany: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 54: Germany: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 55: France: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 56: France: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 57: United Kingdom: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 58: United Kingdom: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 59: Italy: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 60: Italy: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 61: Spain: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 62: Spain: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 63: Russia: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 64: Russia: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 65: Others: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 66: Others: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 67: Latin America: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 68: Latin America: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 69: Brazil: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 70: Brazil: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 71: Mexico: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 72: Mexico: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 73: Others: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 74: Others: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 75: Middle East and Africa: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 76: Middle East and Africa: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 77: Global: Asthma Therapeutics Industry: SWOT Analysis
- Figure 78: Global: Asthma Therapeutics Industry: Value Chain Analysis
- Figure 79: Global: Asthma Therapeutics Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Asthma Therapeutics Market: Key Industry Highlights, 2023 and 2032
- Table 2: Global: Asthma Therapeutics Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032
- Table 3: Global: Asthma Therapeutics Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
- Table 4: Global: Asthma Therapeutics Market Forecast: Breakup by Treatment Type (in Million US$), 2024-2032
- Table 5: Global: Asthma Therapeutics Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
- Table 6: Global: Asthma Therapeutics Market Forecast: Breakup by Region (in Million US$), 2024-2032
- Table 7: Global: Asthma Therapeutics Market Structure
- Table 8: Global: Asthma Therapeutics Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.